Equillium (EQ) Shares Outstanding (Diluted Average) (2021 - 2026)

Equillium (EQ) reported Shares Outstanding (Diluted Average) of $96.3 million for Q1 2026, up 170.55% year-over-year from $35.6 million in Q1 2025, and up 68.01% quarter-over-quarter from $57.3 million in Q4 2025.

Equillium (EQ) Shares Outstanding (Diluted Average) (2021 - 2026) Analysis & Trends

Equillium (EQ) has 6 years of Shares Outstanding (Diluted Average) data on file, last reported at $96.3 million in Q1 2026.

  • Shares Outstanding (Diluted Average) for Q1 2026 came in at $96.3 million, up 170.55% year-over-year; the trailing twelve-month figure through Mar 2026 was $96.3 million (up 170.55% YoY), and the FY2025 annual result was $57.3 million, up 62.07% from the prior year.
  • Shares Outstanding (Diluted Average) climbed to $96.3 million in Q1 2026 per EQ's latest filing, from $57.3 million in the prior quarter.
  • Over five years, Shares Outstanding (Diluted Average) peaked at $96.3 million in Q1 2026 and troughed at $31.9 million in Q1 2022.
  • A 5-year average of $41.3 million and a median of $35.3 million in 2024 frame the typical range for Shares Outstanding (Diluted Average).
  • The sharpest annual moves came in 2025 and 2026: Shares Outstanding (Diluted Average) grew 0.94% in 2025, then soared 170.55% in 2026.
  • A 5-year view of Shares Outstanding (Diluted Average) shows it stood at $33.7 million in 2022, then grew by 2.96% to $34.7 million in 2023, then advanced by 1.82% to $35.4 million in 2024, then soared by 62.07% to $57.3 million in 2025, then surged by 68.01% to $96.3 million in 2026.
  • Business Quant data shows EQ's Shares Outstanding (Diluted Average) at $96.3 million in Q1 2026, $57.3 million in Q4 2025, and $65.3 million in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Shares (Diluted Avg.) (Qtr)
1 Alterity Therapeutics 925,601.88 Bn 925,601.85 Bn - -
2 Belite Bio 58,560.00 Bn 58,560.00 Bn - -
3 Quantum Biopharma 17,284.41 Bn 17,284.40 Bn - 4,489.46 Bn
4 Legend Biotech 2,809.00 Bn 2,808.71 Bn 242.10 Mn 810.00
5 Evaxion A 1,334.43 Bn 1,334.42 Bn - -
6 Akari Therapeutics 1,312.27 Bn 1,312.26 Bn - 118.76 Bn
7 Psyence Biomedical 212.16 Bn 212.16 Bn - 1.48 Bn
8 Vertex Pharmaceuticals 114.83 Bn 107.58 Bn 2.59 Bn 256.30 Mn
9 Abivax 91.96 Bn 91.96 Bn - 92.44 Mn
10 Equillium 293.17 Mn 232.78 Mn - 96.28 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 96.28 Mn
Dec 31, 2025 57.30 Mn
Sep 30, 2025 65.32 Mn
Jun 30, 2025 35.72 Mn
Mar 31, 2025 35.59 Mn
Dec 31, 2024 35.36 Mn
Sep 30, 2024 35.32 Mn
Jun 30, 2024 35.27 Mn
Mar 31, 2024 35.25 Mn
Dec 31, 2023 34.73 Mn
Sep 30, 2023 34.58 Mn
Jun 30, 2023 34.45 Mn
Mar 31, 2023 34.41 Mn
Dec 31, 2022 33.73 Mn
Sep 30, 2022 33.51 Mn
Jun 30, 2022 33.09 Mn
Mar 31, 2022 31.87 Mn
Dec 31, 2021 28.81 Mn
Sep 30, 2021 29.38 Mn
Jun 30, 2021 29.08 Mn